Skip to content

Clinical trials

Attention Deficit Disorder with Hyperactivity trials in Spain with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Phase: Not applicable Country / region: Spain Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20132
20141
20161
20181
20191
20201
20222
20232
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status3
Not yet recruiting2
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospital Universitari Vall d'Hebron Research Institute3
Fundació Sant Joan de Déu2
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina1
Hospital El Escorial1
Hospital Vall d'Hebron1
JJ JIMENEZ-REJANO1
Laboratorios Ordesa1
Spanish Foundation for Neurometrics Development1
Spanish National Research Council1
Universidad Rey Juan Carlos1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity18
Mental Disorders3
Autism Spectrum Disorder2
Autistic Disorder2
Bipolar Disorder2
Bipolar and Related Disorders1
Borderline Personality Disorder1
Compulsive Personality Disorder1
Obesity1
Personality Disorders1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.